1 option
Cost-Offsets of New Medications for Treatment of Schizophrenia / Richard G. Frank, Thomas G. McGuire, Sharon-Lise Normand.
- Format:
- Book
- Author/Creator:
- Frank, Richard G.
- Series:
- Working Paper Series (National Bureau of Economic Research) no. w12643.
- NBER working paper series no. w12643
- Language:
- English
- Physical Description:
- 1 online resource: illustrations (black and white);
- Place of Publication:
- Cambridge, Mass. National Bureau of Economic Research 2006.
- Summary:
- Broad claims are frequently made that new medications will offset all or part of their costs by reducing other areas of Medicaid spending. In this paper we examine the net impact on spending for new drugs used to treat schizophrenia. We extend research in this area by taking a new approach to identification of spending impacts of new drugs. We specify and estimate models of spending on treatment of schizophrenia using 7 years of Florida Medicaid data. The estimates indicate that use of the new drugs result in net spending increases. This may be due to increased adherence to treatment.
- Notes:
- October 2006.
- Print version record
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.